MedPath

Zhejiang Hisoar Pharmaceutical Co., Ltd.

Ownership
-
Established
1998-05-07
Employees
2.6K
Market Cap
-
Website
www.hisoar.com
Introduction

The company is a listed company controlled by Donggang Group that mainly produces specialty APIs, formulations, fine chemicals, dyes and dye intermediates. It is one of the top 100 enterprises in the national pharmaceutical industry with innovative capabilities, a key high-tech enterprise of the National Torch Program, the first batch of honest demonstration enterprises in Zhejiang Province, and an excellent self-operated export manufacturer in Zhejiang Province. The company's main business is chemical pharmaceuticals. The company's main products include R&D and commercial production and sales of specialty APIs, pharmaceutical intermediates, and generic drugs, and provides customized R&D and production services (CMO/CDMO), environmentally friendly active dyes, anthraquinone dyes and dye pigment intermediates for world-renowned pharmaceutical companies. Corporate honors: The company's enterprise technology center is a “national enterprise technology center”, with a national postdoctoral workstation, Zhejiang academician expert workstations, and two provincial enterprise research institutes, Haixiang Pharmaceutical and Taizhou Qianjin. It has completed 13 national projects and 35 provincial projects, and has 44 domestic invention patents, 2 PCT patents, 7 national standards, 8 industry standards, and 11 Zhejiang science and technology awards.

© Copyright 2025. All Rights Reserved by MedPath